SVR24 rates in patients with HCV genotype 5 and 6 infection treated with peginterferon alfa-2a (40KD) plus ribavirin: Results from the real world PROPHESYS study

François D'heygere; Christophe George; François Habersetzer; Davender Tripathi; Calvin Q. Pan; Jose A. Giron; Manuela Schmitz; Fernando Tatsch

doi:10.1016/s1665-2681(19)30896-8

SVR24 rates in patients with HCV genotype 5 and 6 infection treated with peginterferon alfa-2a (40KD) plus ribavirin: Results from the real world PROPHESYS study

François D'heygere
, Christophe George
, François Habersetzer
, Davender Tripathi
, Calvin Q. Pan
, Jose A. Giron
, Manuela Schmitz
, Fernando Tatsch

Research output: Contribution to journal › Letter › peer-review

Original language	English
Pages (from-to)	303-304
Number of pages	2
Journal	Annals of Hepatology
Volume	13
Issue number	2
DOIs	https://doi.org/10.1016/s1665-2681(19)30896-8
State	Published - 2014
Externally published	Yes

Access to Document

10.1016/s1665-2681(19)30896-8

Cite this

@article{5c3515ea9e2f4f54975c032b446d70f6,

title = "SVR24 rates in patients with HCV genotype 5 and 6 infection treated with peginterferon alfa-2a (40KD) plus ribavirin: Results from the real world PROPHESYS study",

author = "Fran{\c c}ois D'heygere and Christophe George and Fran{\c c}ois Habersetzer and Davender Tripathi and Pan, \{Calvin Q.\} and Giron, \{Jose A.\} and Manuela Schmitz and Fernando Tatsch",

year = "2014",

doi = "10.1016/s1665-2681(19)30896-8",

language = "English",

volume = "13",

pages = "303--304",

journal = "Annals of Hepatology",

issn = "1665-2681",

publisher = "Elsevier Espana S.L.U",

number = "2",

}

TY - JOUR

T1 - SVR24 rates in patients with HCV genotype 5 and 6 infection treated with peginterferon alfa-2a (40KD) plus ribavirin

T2 - Results from the real world PROPHESYS study

AU - D'heygere, François

AU - George, Christophe

AU - Habersetzer, François

AU - Tripathi, Davender

AU - Pan, Calvin Q.

AU - Giron, Jose A.

AU - Schmitz, Manuela

AU - Tatsch, Fernando

PY - 2014

Y1 - 2014

UR - https://www.scopus.com/pages/publications/84893689977

U2 - 10.1016/s1665-2681(19)30896-8

DO - 10.1016/s1665-2681(19)30896-8

M3 - Letter

C2 - 24558225

AN - SCOPUS:84893689977

SN - 1665-2681

VL - 13

SP - 303

EP - 304

JO - Annals of Hepatology

JF - Annals of Hepatology

IS - 2

ER -